Melincoff Gwen A

Melincoff Gwen A is listed in filings as Director at Protalix BioTherapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 4, 2025, including 4 public disclosures. Recent filings connect the profile to Protalix BioTherapeutics, Inc. (PLX) and Gain Therapeutics, Inc. (GANX). The current snapshot covers public activity from Jun 26, 2024 to Sep 4, 2025. Reported amounts are shown as $24.6K to $19.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.